Healthcare provider profile · identity verified

David Allen Mcintyre, MD

Family Practice · NORTHFIELD, MN · NPI 1821058074

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	311	88
Amlodipine Besylate	Amlodipine Besylate	223	65
Omeprazole	Omeprazole	223	58
Gabapentin	Gabapentin	181	47
Metformin Hcl Er	Metformin Hcl	174	50
Levothyroxine Sodium	Levothyroxine Sodium	162	39
Furosemide	Furosemide	159	38
Lisinopril	Lisinopril	153	44
Metoprolol Succinate	Metoprolol Succinate	146	49
Oxycodone Hcl	Oxycodone Hcl	125	31
Losartan Potassium	Losartan Potassium	123	41
Tamsulosin Hcl	Tamsulosin Hcl	119	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	113	31
Albuterol Sulfate Hfa	Albuterol Sulfate	106	28
Glimepiride	Glimepiride	101	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	17
Celecoxib	Celecoxib	90	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	29
Rosuvastatin Calcium	Rosuvastatin Calcium	89	29
Escitalopram Oxalate	Escitalopram Oxalate	87	30
Simvastatin	Simvastatin	85	21
Metoprolol Tartrate	Metoprolol Tartrate	84	22
Lorazepam	Lorazepam	82	19
Allopurinol	Allopurinol	72	24
Pregabalin	Pregabalin	72	15
Bupropion Xl	Bupropion Hcl	71	20
Zolpidem Tartrate	Zolpidem Tartrate	66	17
Duloxetine Hcl	Duloxetine Hcl	64	13
Tramadol Hcl	Tramadol Hcl	64	15
Fluticasone Propionate	Fluticasone Propionate	63	19
Pantoprazole Sodium	Pantoprazole Sodium	63	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	13
Trazodone Hcl	Trazodone Hcl	58	20
Mounjaro	Tirzepatide	57	suppressed
Sertraline Hcl	Sertraline Hcl	53	17
Hydrochlorothiazide	Hydrochlorothiazide	50	17
Prednisone	Prednisone	50	26
Clonazepam	Clonazepam	49	suppressed
Spironolactone	Spironolactone	48	11
Carvedilol	Carvedilol	47	14
Ropinirole Hcl	Ropinirole Hcl	47	12
Humalog Kwikpen U-100	Insulin Lispro	46	suppressed
Xarelto	Rivaroxaban	46	suppressed
Mirtazapine	Mirtazapine	44	12
Potassium Chloride	Potassium Chloride	44	12
Famotidine	Famotidine	43	suppressed
Eliquis	Apixaban	41	suppressed
Morphine Sulfate Er	Morphine Sulfate	40	suppressed
Warfarin Sodium	Warfarin Sodium	40	suppressed
Ozempic	Semaglutide	38	suppressed
Naproxen	Naproxen	36	12
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	36	14
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Trulicity	Dulaglutide	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	11
Atenolol	Atenolol	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Chlorthalidone	Chlorthalidone	25	11
Meloxicam	Meloxicam	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Torsemide	Torsemide	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Glipizide	Glipizide	22	suppressed
Lactulose	Lactulose	22	suppressed
Topiramate	Topiramate	22	suppressed
Baclofen	Baclofen	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	17
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	20	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	19	suppressed
Morphine Sulfate	Morphine Sulfate	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Estradiol	Estradiol	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Azithromycin	Azithromycin	17	15
Clonidine Hcl	Clonidine Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	12
Ibuprofen	Ibuprofen	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Metformin Hcl	Metformin Hcl	16	suppressed
Minocycline Hcl	Minocycline Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Emgality Pen	Galcanezumab-Gnlm	14	suppressed
Finasteride	Finasteride	14	suppressed
Cephalexin	Cephalexin	13	12
Dantrolene Sodium	Dantrolene Sodium	13	suppressed
Nadolol	Nadolol	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Xifaxan	Rifaximin	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	11	11
Montelukast Sodium	Montelukast Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error